Thermogenesis prices $2.05 million public offering

Rancho cordova, calif. , oct. 25, 2022 /prnewswire/ -- thermogenesis holdings, inc. (nasdaq: thmo) (the "company"), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the pricing of its public offering of 11,783,572 shares of its common stock, $0.001 par value (the "common shares") (or pre-funded warrants to purchase common shares in lieu thereof) and warrants to purchase up to an aggregate 11,783,572 common shares at an offering price to the public of $0.14 per share (or pre-funded warrant to purchase common shares in lieu thereof) and associated warrant.
THMO Ratings Summary
THMO Quant Ranking